About Accucaps
Accucaps is a Healthcare company based in Windsor (Canada) founded in 1989, and was acquired by Catalent in November 2016. Softgel formulations are contract developed and manufactured. Accucaps offers products and services including RP Scherer Softgel, Vegicaps® Capsules, EasyBurst® Chewable Softgels, and CosmoPod® Capsules. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Catalent, Inc.
Company details
Accucaps was founded in 1989 in Windsor, Canada, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on soft-gel based oral drug delivery formulations, including proprietary multiphase products such as tablets in capsules and liquids in capsules. Facilities are inspected regularly by the US FDA and Health Canada. Packaging solutions, including pack development and child-resistant testing, are also provided.
Products & Services of Accucaps
Accucaps offers a comprehensive portfolio of products and services, including RP Scherer Softgel, Vegicaps® Capsules, EasyBurst® Chewable Softgels, and CosmoPod® Capsules.
Advanced softgel technology for improved bioavailability in consumer health.
Plant-based encapsulation for nutritional and beauty supplements.
Chewable forms for enhanced taste and ease in supplement delivery.
Unit-dose capsules for targeted beauty and health formulations.
Apps and channels of Accucaps
its YouTube channel Catalent Pharma Solutions has 7.59K subscribers and 30 videos.
Videos from Accucaps
The most watched videos on Accucaps's YouTube channel, Catalent Pharma Solutions (7.59K subscribers). Click a video to play it here.
More on Catalent Pharma Solutions.
Investors in Accucaps
Accucaps has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Catalent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO offering drug and biologics development services | 2007 | catalent.com | Somerset, United States |
Investor details for Accucaps
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Accucaps
2 dated milestones of Accucaps across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Accucaps is founded.
- Exit Acquired by Catalent.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accucaps
Complete news archive for Accucaps
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accucaps
Accucaps was founded in 1989.
Accucaps is headquartered in Windsor, Canada. It is registered at Windsor, Ontario, Canada.
Accucaps was founded in 1989 in Windsor, Canada, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on soft-gel based oral drug delivery formulations, including proprietary multiphase products such as tablets in capsules and liquids in capsules. Facilities are inspected regularly by the US FDA and Health Canada. Packaging solutions, including pack development and child-resistant testing, are also provided.
Accucaps offers RP Scherer Softgel, Vegicaps® Capsules, EasyBurst® Chewable Softgels, and CosmoPod® Capsules.
Accucaps has 1 investor. Key investors include Catalent.
Accucaps operates through Catalent, Inc.
Yes. Accucaps was acquired by Catalent in November 2016.